Charles A. Reinhart III - 06 Jun 2023 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Financial Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
06 Jun 2023
Net transactions value
-$100,106
Form type
4
Filing time
07 Jun 2023, 21:29:34 UTC
Previous filing
08 Jun 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale $48,193 -1,236 -3.4% $38.99 34,997 06 Jun 2023 Direct F1
transaction PCRX Common Stock Sale $51,913 -1,371 -3.9% $37.86 33,626 07 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.